- Home
- SNES vs ISPC Comparison
SNES vs ISPC Comparison
Compare SNES & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNES
- ISPC
- Stock Information
- Founded
- SNES 2004
- ISPC 2009
- Country
- SNES United States
- ISPC United States
- Employees
- SNES N/A
- ISPC N/A
- Industry
- SNES Agricultural Chemicals
- ISPC Precision Instruments
- Sector
- SNES Industrials
- ISPC Health Care
- Exchange
- SNES Nasdaq
- ISPC Nasdaq
- Market Cap
- SNES 2.3M
- ISPC 2.0M
- IPO Year
- SNES 2016
- ISPC 2021
- Fundamental
- Price
- SNES $3.03
- ISPC $1.74
- Analyst Decision
- SNES Strong Buy
- ISPC
- Analyst Count
- SNES 1
- ISPC 0
- Target Price
- SNES $10.00
- ISPC N/A
- AVG Volume (30 Days)
- SNES 97.2K
- ISPC 120.7K
- Earning Date
- SNES 02-28-2025
- ISPC 03-12-2025
- Dividend Yield
- SNES N/A
- ISPC N/A
- EPS Growth
- SNES N/A
- ISPC N/A
- EPS
- SNES N/A
- ISPC N/A
- Revenue
- SNES $1,651,000.00
- ISPC $10,390,702.00
- Revenue This Year
- SNES $76.36
- ISPC $13.82
- Revenue Next Year
- SNES $103.47
- ISPC $11.76
- P/E Ratio
- SNES N/A
- ISPC N/A
- Revenue Growth
- SNES 38.16
- ISPC 0.74
- 52 Week Low
- SNES $1.90
- ISPC $1.73
- 52 Week High
- SNES $9.80
- ISPC $11.80
- Technical
- Relative Strength Index (RSI)
- SNES 47.13
- ISPC 32.34
- Support Level
- SNES $3.18
- ISPC $1.76
- Resistance Level
- SNES $3.63
- ISPC $1.99
- Average True Range (ATR)
- SNES 0.42
- ISPC 0.16
- MACD
- SNES 0.00
- ISPC 0.02
- Stochastic Oscillator
- SNES 31.26
- ISPC 2.13
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.